NUVA Fundamental Analysis - NORATIS AG

Fundamental Rating

NUVA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 66 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of NUVA have multiple concerns. While showing a medium growth rate, NUVA is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NUVA has reported negative net income.

NUVA had a positive operating cash flow in the past year.

NUVA had positive earnings in 4 of the past 5 years.

NUVA had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

NUVA's Return On Assets of -6.08% is on the low side compared to the rest of the industry. NUVA is outperformed by 66.67% of its industry peers.

With a Return On Equity value of -42.03%, NUVA is not doing good in the industry: 75.76% of the companies in the same industry are doing better.

NUVA has a Return On Invested Capital (1.00%) which is in line with its industry peers.

The Average Return On Invested Capital over the past 3 years for NUVA is in line with the industry average of 3.78%.

		Industry Rank	Sector Rank
ROA	-6.08%
ROE	-42.03%
ROIC	1%

ROA(3y)0.49%

ROA(5y)1.08%

ROE(3y)2.81%

ROE(5y)5.59%

ROIC(3y)2.51%

ROIC(5y)2.76%

1.3 Margins

NUVA's Operating Margin of 12.12% is in line compared to the rest of the industry. NUVA outperforms 57.58% of its industry peers.

NUVA's Operating Margin has declined in the last couple of years.

With a Gross Margin value of 33.21%, NUVA perfoms like the industry average, outperforming 48.48% of the companies in the same industry.

In the last couple of years the Gross Margin of NUVA has declined.

		Industry Rank	Sector Rank
OM	12.12%
PM (TTM)	N/A
GM	33.21%

OM growth 3Y-12.49%

OM growth 5Y-25.35%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-15.23%

GM growth 5Y-19.43%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NUVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

NUVA has more shares outstanding than it did 1 year ago.

NUVA has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, NUVA has about the same debt to assets ratio.

2.2 Solvency

NUVA has an Altman-Z score of 1.34. This is a bad value and indicates that NUVA is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.34, NUVA is in the better half of the industry, outperforming 69.70% of the companies in the same industry.

The Debt to FCF ratio of NUVA is 25.77, which is on the high side as it means it would take NUVA, 25.77 years of fcf income to pay off all of its debts.

NUVA has a Debt to FCF ratio of 25.77. This is comparable to the rest of the industry: NUVA outperforms 54.55% of its industry peers.

NUVA has a Debt/Equity ratio of 5.06. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 5.06, NUVA is not doing good in the industry: 83.33% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	5.06
Debt/FCF	25.77
Altman-Z	1.34

ROIC/WACC0.31

WACC3.25%

2.3 Liquidity

A Current Ratio of 7.75 indicates that NUVA has no problem at all paying its short term obligations.

NUVA's Current ratio of 7.75 is amongst the best of the industry. NUVA outperforms 95.45% of its industry peers.

NUVA has a Quick Ratio of 7.75. This is a bad value and indicates that NUVA is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.34, NUVA is doing worse than 68.18% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	7.75
Quick Ratio	0.34

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for NUVA have decreased strongly by -628.53% in the last year.

Looking at the last year, NUVA shows a decrease in Revenue. The Revenue has decreased by -6.90% in the last year.

The Revenue has been growing slightly by 1.41% on average over the past years.

EPS 1Y (TTM)-628.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-321.33%

Revenue 1Y (TTM)-6.9%

Revenue growth 3Y27.99%

Revenue growth 5Y1.41%

Sales Q2Q%-38.01%

3.2 Future

Based on estimates for the next years, NUVA will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.58% on average per year.

Based on estimates for the next years, NUVA will show a quite strong growth in Revenue. The Revenue will grow by 13.83% on average per year.

EPS Next Y-154.43%

EPS Next 2Y26.68%

EPS Next 3Y24.72%

EPS Next 5Y16.58%

Revenue Next Year-2.16%

Revenue Next 2Y37.08%

Revenue Next 3Y30.59%

Revenue Next 5Y13.83%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NUVA. In the last year negative earnings were reported.

Also next year NUVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

NUVA's Enterprise Value to EBITDA ratio is in line with the industry average.

NUVA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NUVA is cheaper than 98.48% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	0.77
EV/EBITDA	60.58

4.3 Compensation for Growth

NUVA's earnings are expected to grow with 24.72% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y26.68%

EPS Next 3Y24.72%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for NUVA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NORATIS AG

FRA:NUVA (6/16/2025, 7:00:00 PM)

0.845

-0.03 (-3.43%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryReal Estate Management & Development

Earnings (Last)05-25 2025-05-25/amc

Earnings (Next)09-29 2025-09-29

Inst Owners0.55%

Inst Owner ChangeN/A

Ins Owners2.11%

Ins Owner ChangeN/A

Market Cap11.47M

Analysts40

Price Target1.09 (28.99%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.24
P/FCF	0.77
P/OCF	0.77
P/B	0.18
P/tB	0.18
EV/EBITDA	60.58

EPS(TTM)-4.25

EYN/A

EPS(NY)-0.66

Fwd EYN/A

FCF(TTM)1.09

FCFY129.38%

OCF(TTM)1.09

OCFY129.51%

SpS3.5

BVpS4.82

TBVpS4.82

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.08%
ROE	-42.03%
ROCE	1.45%
ROIC	1%
ROICexc	1.03%
ROICexgc	1.03%
OM	12.12%
PM (TTM)	N/A
GM	33.21%
FCFM	31.26%

ROA(3y)0.49%

ROA(5y)1.08%

ROE(3y)2.81%

ROE(5y)5.59%

ROIC(3y)2.51%

ROIC(5y)2.76%

ROICexc(3y)2.58%

ROICexc(5y)2.87%

ROICexgc(3y)2.58%

ROICexgc(5y)2.87%

ROCE(3y)3.63%

ROCE(5y)4%

ROICexcg growth 3Y3.42%

ROICexcg growth 5Y-34.46%

ROICexc growth 3Y3.42%

ROICexc growth 5Y-34.46%

OM growth 3Y-12.49%

OM growth 5Y-25.35%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-15.23%

GM growth 5Y-19.43%

F-Score3

Asset Turnover0.11

Health

		Industry Rank	Sector Rank
Debt/Equity	5.06
Debt/FCF	25.77
Debt/EBITDA	52.51
Cap/Depr	2.76%
Cap/Sales	0.03%
Interest Coverage	0.31
Cash Conversion	235.94%
Profit Quality	N/A
Current Ratio	7.75
Quick Ratio	0.34
Altman-Z	1.34

F-Score3

WACC3.25%

ROIC/WACC0.31

Cap/Depr(3y)21.85%

Cap/Depr(5y)22.27%

Cap/Sales(3y)0.13%

Cap/Sales(5y)0.16%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-628.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-321.33%

EPS Next Y-154.43%

EPS Next 2Y26.68%

EPS Next 3Y24.72%

EPS Next 5Y16.58%

Revenue 1Y (TTM)-6.9%

Revenue growth 3Y27.99%

Revenue growth 5Y1.41%

Sales Q2Q%-38.01%

Revenue Next Year-2.16%

Revenue Next 2Y37.08%

Revenue Next 3Y30.59%

Revenue Next 5Y13.83%

EBIT growth 1Y-39.66%

EBIT growth 3Y12.01%

EBIT growth 5Y-24.3%

EBIT Next Year-79.85%

EBIT Next 3Y25.36%

EBIT Next 5Y23.98%

FCF growth 1Y134.63%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y134.74%

OCF growth 3YN/A

OCF growth 5YN/A

NORATIS AG (NUVA.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens